Month: June 2024

USPTF on Kids with Obesity_ GLP-1s on Brain Diseases_ Financial Incentives to Lose Weight_ Novel Amylin Drug Drives 8.6% Weight Loss at 16 Weeks

USPTF on Kids with Obesity; GLP-1s on Brain Diseases; Financial Incentives to Lose Weight; Novel Amylin Drug Drives 8.6% Weight Loss at 16 Weeks

June 23, 2024 No Comments

AT A GLANCE The US Preventive Services Task Force published in JAMA a Recommendation Statement on Interventions for High Body Mass Index in Children and Adolescents. Simar Bajaj at NewScientist on GLP-1s’ unexpected effects on the brain, to treat depression, anxiety, addiction and Alzheimer’s. JAMA Pediatrics publishes the impact of financial incentives on improved outcomes of a dietary intervention among 126 adolescents with severe obesity. Zealand Pharma drug petrelintide, which targets the

Read More »
MASH-Clash-for-Liver-Disease;-Google’s-Verily-Pivots-to-GLP-1-Meds;-JPMorgan-Chase-$500M-Bet-on-Weight-Loss-Meds;-MIT’s-Bob-Langer-Launches-NewCo;-40%-Increase-in-Type-2-Diabetes-in-Young-People

MASH Clash for Liver Disease; Google’s Verily Pivots to GLP-1 Meds; JPMorgan Chase $500M Bet on Weight-Loss Meds; MIT’s Bob Langer Launches NewCo; 40% Increase in Type 2 Diabetes in Young People

June 16, 2024 No Comments

AT A GLANCE STAT on Google’s health tech spinout Verily pivoting to offer GLP-1 drug prescriptions. MIT biotech legend Bob Langer and colleague Giovanni Traverso launched Syntis Bio, with a technology to coat the stomach, that impacts obesity. From Yahoo! Finance, JPMorgan Chase & Co.’s asset-management arm raised a  $500 million fund to invest in weight-loss drugs. From Reuters, roughly one-third of US employer health plans are covering

Read More »
Oral GLP-1 Charge; Weight Loss Drugs and Cancer; The Obese Police; Medicaid Coverage for Comprehensive Obesity Care.

Oral GLP-1 Charge; Weight Loss Drugs and Cancer; The Obese Police; Medicaid Coverage for Comprehensive Obesity Care.

June 9, 2024 No Comments

AT A GLANCE Structure Therapeutics announced weight loss of 6.2% at 12 weeks in 37 subjects on GSBR-1290 – a once-daily oral GLP-1 drug. UK-based The Guardian newspaper reports ‘…Weight-loss drugs offer a new weapon in the global fight against cancer…’ STAT notes Eli Lilly’s Zepbound obesity drug ‘…improved living scarring in a mid-stage study of the liver disease MASH.’ Tamar Haspel at The Atlantic refers to new guidelines

Read More »
Nestle Frozen Foods for GLP-1 Users; Weight-Loss Drug Sales in 2033 Balloon to $150B; No Staying Power Beyond 12 Weeks; Black Americans are Left Out.

Nestle Frozen Foods for GLP-1 Users; Weight-Loss Drug Sales in 2033 Balloon to $150B; No Staying Power Beyond 12 Weeks; Black Americans are Left Out.

June 2, 2024 No Comments

AT A GLANCE CNN on Nestle ‘…releasing a lineup of frozen food for people on Ozempic and other GLP-1 drugs.’ Deena Beasley at Reuters reports BMO Capital Markets now estimates annual weight-loss drug sales reaching $150 billion by 2033. South Park; The End of Obesity is very good satire, and eerily realistic. Anissa Durham on STAT ‘…New obesity drugs are seemingly everywhere. Black Americans feel left out.’

Read More »
Categories
Archives
Scroll to Top
Skip to content